ACADIA Pharmaceuticals (ACAD)

Add to Watchlists
Create an Alert
17.46 +0.46  +2.71% NASDAQ May 24, 15:03 Delayed 2m USD

ACADIA Pharmaceuticals Balance Sheet (Quarterly)

Export Data

March 2018 - December 2015

Previous Periods

Assets (Quarterly) 2018-03 2017-12 2017-09 2017-06 2017-03 2016-12 2016-09 2016-06 2016-03 2015-12
Cash and Equivalents Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Short Term Investments Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Cash and Short Term Investments 298.06M 341.34M 366.62M 417.32M 469.48M 529.04M 588.86M 412.56M 457.24M 215.13M
Accounts Receivable 22.45M 17.34M 14.22M 11.59M 7.660M 5.903M 3.839M 0.2930M 0.000
Total Receivables Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Raw Materials Inventory Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Finished Goods Inventory Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Inventories 5.583M 5.248M 5.536M 6.003M 3.881M 4.175M 4.301M 2.867M 0.000
Prepaid Expenses Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Restricted Cash Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Other Current Assets Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Total Current Assets Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Properties Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Buildings and Improvements Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Machine, Furniture & Equipment Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Other Properties Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Construction in Progress Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Leases Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Gross PP&E Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Accumulated D&A Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Net PP&E 2.709M 2.662M 2.991M 3.296M 3.471M 3.081M 3.159M 2.897M 2.623M 2.203M
Other Intangible Assets Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Goodwill and Intangibles Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Other Long Term Assets Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Total Long Term Assets Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Total Assets 351.04M 384.51M 413.71M 456.31M 503.01M 561.15M 617.38M 438.03M 466.59M 221.90M
Liabilities (Quarterly) 2018-03 2017-12 2017-09 2017-06 2017-03 2016-12 2016-09 2016-06 2016-03 2015-12
Accounts Payable 2.996M 8.786M 2.962M 3.588M 2.166M 3.912M 2.828M 1.024M 1.307M 1.672M
Total Payables Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Accrued Expenses Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Payables and Accrued Expenses Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Current Portion of Long Term Debt Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Current Debt & Capital Lease Obligation Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Current Deferred Revenue Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Current Deferred Liabilities Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Other Current Liability Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Total Current Liabilities Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Non-Current Portion of Long Term Debt Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Non-Current Portion of LTD and Capital Lease Obligation Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Non-Current Deferred Revenue Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Non-Current Deferred Liabilities Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Preferred Securities out of Shareholders Equity Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Other Long Term Liabilities Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Total Long Term Liabilities Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Total Liabilities 46.87M 49.22M 36.39M 41.17M 45.49M 42.74M 39.33M 29.22M 21.34M 22.13M
Shareholder's Equity (Quarterly) 2018-03 2017-12 2017-09 2017-06 2017-03 2016-12 2016-09 2016-06 2016-03 2015-12
Total Capital Stock Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Retained Earnings -1.278B -1.224B -1.155B -1.090B -1.022B -933.98M -855.28M -783.67M -712.35M -662.59M
Additional Paid In Capital Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Adjustments for Foreign Currency Translation Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Other Equity Adjustments Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Accrued Comprehensive Inc Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Shareholders Equity 304.17M 335.29M 377.33M 415.14M 457.52M 518.41M 578.06M 408.81M 445.25M 199.76M
SEC Filing Links 2018-03 2017-12 2017-09 2017-06 2017-03 2016-12 2016-09 2016-06 2016-03 2015-12
As Originally Reported AOR AOR AOR AOR AOR AOR AOR AOR AOR AOR
Restated Restated Restated Restated Restated Restated Restated

March 2018 - December 2015

Previous Periods

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.